chrisvoncsefalvay/vaers-outcomes huggingface dataset:
two staff members who tested positive for covid after receiving the first dose.; two staff members who tested positive for covid after receiving the first dose.; This is a spontaneous report from the Pfizer Sponsored Program called 'Pfizer First Connect' received by a contactable pharmacist. This pharmacist reported similar events for 2 staff members. This is 2nd of 2 reports.   A patient (demographics unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, in Dec2020 at single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. On unknown date, after first shot of vaccine, COVID test resulted positive. The reporting pharmacist is asking about the recommendation regarding taking the second shot. The outcome of the event was unknown.  Information about Batch/Lot number has been requested.; Sender's Comments: A causal association between reported event and suspect BNT162B2 cannot be excluded. ,Linked Report(s) : US-PFIZER INC-2021010495 Same reporter/ drug/ event for different patients.
Pt Recieved firts  Pfizer  covid shot  on May 7 , ( Shot was given at Pharmacy )     over the next week, not feeling well, body aches, headache, ect.    by the started felling better on the 15th of May , then took a turn for the worse.   On the 18th, hypodermic Temp 95, severe dyspnea on May 19th.  Pt was checked into Medical Center, on the 19th May.  A Lymphnode on his Clavicle was found and was found to have lymphoma.   Also, his Sister, believes that he had his second Pfizer Covid shot on May 20. and that he tested pos for Covid.  He was sent home on the 4th of June. He came back to my emergency room on the 10th of June for respiratory failue., was intubated and sent to the ICU where he expired on June  24.
Vaccine administered 2/28/13. Per CPRS patient called clinic to report reaction to 'shot in right arm' in February (swelling of right arm, fever). He states he had to get medication from private doctor to 'counteract reaction'.
pins and needles on the skin; itching on the skin/itching all over her body; burning sensation on the skin; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 23Jul2021 (Batch/Lot Number: ER8729) as dose 1, single for covid-19 immunization (at the age of 61-years-old). Medical history included asthma (controlled and nothing has flared up), Porphyria cutanea tarda (it was formally diagnosed last year but she has had issues on and off her whole life but didn't notice) and allergic to sulfa based drugs all from an unknown date and unknown if ongoing. The patient previously took penicillin [penicillin nos] and was allergic to Penicillin. The patient stated that she received the first dose of vaccine on 23Jul2021 and within 4 hours she was experiencing burning, pins and needles, and itching all over her body but there was no visible rash or redness on her skin. She further explained that she has a history of PCT which was Porphyria Cutanea Tarda, which was a condition she has with her skin. She rarely has break outs, like 1 break out in her whole life. It was now 2 weeks out today and she was still experiencing the symptoms, it has gone down a little bit in the last couple days but her next shot was schedule on 13Aug2021 on Wednesday and would like to know what should be done in regards to the second dose. She stated that she doesn't know if this was a coincidence or an allergic reaction, but if it were an allergic reaction what should be the protocol for the second dose. The burning sensation, itching, and pins and needles sensation was all ongoing, and has all improved in the last 2 days. Her Second dose is schedule for 13Aug2021. As a treatment She can't take antihistamines because it can set off PCT, but she follows a protocol trying to eat really clean and taking vitamins, no alcohol Kind of like a detox. The adverse event did not result into the emergency room or physician office visit. She did not seek any medical attention because it didn't affect her breathing, it was just a constant burning and itching. The outcome of all the event was recovering at the time of report.
Flu like symptoms; General achiness; The patient reports a red ring around the injection site the size of a nickle; Joint pain; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (General achiness), VACCINATION SITE ERYTHEMA (The patient reports a red ring around the injection site the size of a nickle) and ARTHRALGIA (Joint pain) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (General achiness), VACCINATION SITE ERYTHEMA (The patient reports a red ring around the injection site the size of a nickle) and ARTHRALGIA (Joint pain). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (General achiness), VACCINATION SITE ERYTHEMA (The patient reports a red ring around the injection site the size of a nickle) and ARTHRALGIA (Joint pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications details were not reported by the reporter. The patient not got COVID-19 infection.  Treatment details were not reported by the reporter.   This case was linked to MOD-2022-614955, MOD-2022-614959 (Patient Link).
Information has been received from a pharmacist concerning an 86 year old female patient with penicillin allergy and sulfa allergy who on 12-APR-2012 was vaccinated SQ with a 0.65mL single dose of ZOSTAVAX (Merck). The physician reported that on 08-MAY-2012 the patient experienced a swollen, hot and itchy arm, from the injection site down to the elbow. It was reported that an unspecified physician prescribed an unspecified antiviral cream, and that symptoms subsequently resolved on an unspecified date. Follow up information was received from the physician who indicated that they were unable to get in touch with the patient. Additional information is not expected.
Approx. 3 hrs after vaccine, client c/o dizziness, increased heart rate, and just not feeling well.
The symptoms started with a cough on that Monday late in the day. A little bit on Tuesday. I did also start feeling a little bit nauseous. The cough proceeded that Tuesday night and I was awake a lot of the night. It hurt my chest but I never felt like I had any congestion or trouble breathing. On 02/01/2023, I took a home COVID-19 test and it was positive after 15 minutes. At that point, I called my doctor's office and left a message saying I tested positive. Later in the day, I got a text notification from my pharmacy for a prescription ready. The doctor's office never called me back, they just sent me the prescription in. I started the PAXLOVID at night on Wednesday 02/01/2023. I did complete the whole regimen even though it made my mouth taste like metal. I got better pretty quickly and I took another test the week of 02/05/2023 around the 9th and I was negative. Then I was all excited because I was negative. Within a couple of days, I started feeling like I was getting a head or sinus cold. I took another test on 02/13/2023 and I had another positive COVID-19 test. I thought maybe it was a false positive and I did another test on 02/14/2023. I never felt bad other than feeling like I had a head cold. I stayed home but I did not feel super sick. I tested again the following midweek and I was negative again. The rebound was very minimal. I wasn't having the horrible cough during the second round. I do also believe that my husband had COVID-19 in December, but when we took at home COVID-19 tests, they came back negative. They were also expired, but it definitely may have been COVID-19 because they were very similar symptoms to what I experienced.
Pt. had unsteady gait walking from immunization room to just outside the store. Fell to sidewalk. Other customer notified me to check on him. Went to him and stayed with him while he regained strength from syncope. Verbal and breathing ok.
Day of vaccine patient was very fussy for remainder of the day. Next day mom noticed rash on buttocks and some lethargy. Second day after vaccine rash started to spread to back and face. Mom has used BENADRYL for the rash and states it has helped some. Nystatin cream was being used prior to vaccine on patient but not in the areas that the rash has developed at. Seen today for the rash, does not look like eczema or any viral rash. Mom notified provider and myself during examination that she is highly allergic to DTaP and had an anaphylaxis reaction to DTaP as a child.
Fast heartbeat, swelling inside right sinus and ear, extreme swelling right side if face, from ear to jaw center and some difficulty breathing.
HEADACHE; FEELS WARM; CHILLS; This spontaneous report received from a consumer concerned a 35 year old male.  The patient's weight was 160 pounds, and height was not reported. The patient's concurrent conditions included non-smoker, and alcohol use, and other pre-existing medical conditions included patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced feels warm. On 07-APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feels warm, and chills on 07-APR-2021, and had not recovered from headache. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Sore arm with raised red bumpy circle at injection site lasting two weeks after injection.  A bruise remained at the location for two more months.   Extra fatigue the first day post injection Burning sensation throughout armpit and breast on right side (injection side) began one week post injection and was very painful for a week then continued sporadically for three to four more weeks.  Felt like lymphatic system was affected.   Seventh pregnancy with five previous live births (1 miscarriage).  Previous babies were born at 40 weeks, 40+6, 41, 42+1, 41+1 all weighing between 6 lbs 12 oz to 8 lbs 1 oz.  This pregnancy the baby was born at 37 weeks and 2 days at 7 lbs 9 oz
Patient reported feeling a headache within an hour of getting flu vaccine on 11/12. The day after (11/13) patient stared feeling dizzy and on 11/ 14 started feeling nauseous. She reports headaches are now resolved, but she was still having some dizziness and nausea when she called the clinic on 11/17. She has a history of diabetes and reports her glucose level was over 500 in the past few days. She denies stroke-like symptoms. Clinic's MD spoke with her on 11/17 and advised her to go to the nearest ED to further testing and evaluation given elevated glucose reading. RN called patient on 11/18 to follow up.
Whole Body in tremendous pain everything hurt; Very Tired; no energy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Apr2021 14:00 (Lot number: ER 8731) at the age of 40 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (lot number=ER8733, administration time=02:00 PM, dose number=1, vaccine location=Left arm), administration date: 26Mar2021, when the patient was 40 years old, for Covid-19 immunisation, reaction(s): "Headache", "Upset stomach", "Tired", "Sore Body", "FLU like symptoms". The following information was reported: PAIN (non-serious), outcome "recovered with sequelae", described as "Whole Body in tremendous pain everything hurt"; FATIGUE (non-serious), outcome "recovered with sequelae", described as "Very Tired"; ASTHENIA (non-serious), outcome "recovered with sequelae", described as "no energy". Therapeutic measures were not taken as a result of pain, fatigue, asthenia.  Additional information: Facility type vaccine was at public health clinic/facility. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. No treatment had received for adverse events. Patient did not receive any other medications within 2 weeks prior to the COVID vaccine. No known allergies and relevant history.  No follow-up attempts are possible. No further information is expected.
Felt dizzy and nauseous a little while after the vaccine. I had to go home early. I felt really tired and slept for 4 hours. Woke up with the chills, body aches, and a pounding headache. This lasted for over 24 hours. I still feel a bit weak and very tired.
OVERDOSE (RECEIVED 2.5 ML OF THE JANSSEN COVID-19 VACCINE); OFF LABEL USE; This spontaneous report received from a health care professional concerned a 79 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A, and expiry: 14-DEC-2021) 2.5 ml, administered on 14-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-NOV-2021, the patient experienced overdose (received 2.5 ml of the janssen covid-19 vaccine). On 14-NOV-2021, the patient experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the overdose (received 2.5 ml of the janssen covid-19 vaccine) and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211220262, 20211220206, 20211220527, 20211220178, 20211220537, 20211220552, 20211220155, 20211220697, 20211220754, 20211219731, 20211219701, 20211219807, 20211219714, 20211220233, 20211220460, 20211220216 and 20211220177.
Systemic: Hypertension-Medium, Additional Details: Patient called and indicated to regulatory authority on duty that the night after receiving the vaccine she felt unwell, took her blood pressure and it was "sky high". She retested in the morning and her blood pressure was back to normal. She denied any changes in medication or food. She said her blood pressure is always normal.
Pt complains of Tinnitus since March 2003, received Anthrax vaccines #1)2/09/03, #2)02/22/03, #3)03/10/03. Obtained hearing exam from private physician
Sneezing; Runny nose; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received first dose of bnt162b2 (Pfizer COVID-19 vaccine, Solution for injection, Batch/lot number: Not Provided, Expiration date: Not Provided), via an unspecified route on 21Feb2021 (age at vaccination: 65-year-old) as a single dose for covid-19 immunization. Medical history included overweight, weighs a little over 200, probably a lot over. The patient concomitant medications were not reported. Patient got her first dose 21Feb2021 and they told her don't take anything but Tylenol for pain, but she needs some decongestant for sneezing and her nose running, she would like to know if she can take Claritin or something for it. She says she was told that some things may counteract the vaccine, so she doesn't want to take something if it might do that. The clinical outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Information has been received from a physician for the pregnancy Registry for GARDASIL concerning a 12 year old female patient with no pertinent medical history, no allergies or drug reactions who on 30-SEP-2011, was vaccinated with the first dose of GARDASIL (route and dose not reported) (lot number 669308/0636AA). On the same day, the patient was vaccinated with the second dose of VARIVAX (Merck) (route and dose not reported) (lot number 669602/0023AA). Concomitant therapy included poliovirus vaccine (manufacturer unknown), influenza virus split virion 3v vaccine inactivated (manufacturer unknown) and HAVRIX. On an unspecified date "after 30-SEP-2011", the patient was evaluated in the emergency room for abdominal pain and was discharged to home. On 10-NOV-2011, the patient had a positive urine pregnancy test LMP: 23-SEP-2011, EDD: 29-JUN-2012. The physician reported that the patient had currently being treated for a sinus infection with ZITHROMAX. At the time of the report the outcome of the patient was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information is not expected.
Headache started approximately 45 minutes after vaccine accompanied with hot flashes. When I got home from hospital the headache had become severe enough that I had to go into a dark room as I was having light and sound sensitivity. Approximately 4 hours after the vaccine I started feeling feverish, chills, aches, nausea. At 9pm that night I was in severe pain from the myalgias, the headache was severe. Took over the counter extra strength Tylenol. At midnight I could not get comfortable. I was having auditory hallucinations thinking that I heard a shout or noise that wasn't there. Temp was never over 101. Started getting an earache at this point. I was awake for 30+ hours with symptoms. Decreased appetite the following day. I was unable to work for 1.5 days. Symptoms started to subside on 7/29 around the 30 hour mark. I was awoken this morning 7/30 at 4am with another of the headaches but I took tylenol and it went away. I had a moderate case of Covid back in December of 2020 and my symptoms after the vaccine mirrored those almost exactly in intensity.
Blurry vision; Dizzy; Lymph node hurt the next day in her neck; Tired; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision), DIZZINESS (Dizzy), LYMPH NODE PAIN (Lymph node hurt the next day in her neck) and FATIGUE (Tired) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Blurry vision), DIZZINESS (Dizzy), LYMPH NODE PAIN (Lymph node hurt the next day in her neck) and FATIGUE (Tired). The patient was treated with AMOXICILLIN ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, VISION BLURRED (Blurry vision), DIZZINESS (Dizzy), LYMPH NODE PAIN (Lymph node hurt the next day in her neck) and FATIGUE (Tired) outcome was unknown.            Concomitant product use was not provided by the reporter.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-142223 (Patient Link).
There was temperature excursion from their freezer on 01Oct2021; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (There was temperature excursion from their freezer on 01Oct2021) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (There was temperature excursion from their freezer on 01Oct2021). On 25-Oct-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (There was temperature excursion from their freezer on 01Oct2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
I woke up with a very large itching bright red rash in my upper right arm with some raised welts. It subsided gradually throughout the day and was gone by around 8:00 p.m. I have not ever had any allergies that I know of except possibly developed a reaction to latex after many years of hospital work.
A report has been received from a Health Professional concerning a patient, Female subject, who had been receiving FLUMIST quadrivalent (intranasal) 0.2 milliliters, once/single administration. FLUMIST quadrivalent started on an unknown date. It was reported that patient number thirteen given FLUMIST that underwent a temperature excursion and it was unknown if the dose of 0.1ml was given in each nostril. FLUMIST quadrivalent was continued. The outcome of the event of patient number thirteen given FLUMIST that underwent a temperature excursion and it is unknown if the dose of 0.1ml was given in each nostril is unknown. The report was considered to be non-serious.
Severe joint pain Neck stiffness unable to move head Full body serve pain unable to walk without assistance holding onto something Any part of the body hurts on contact severely
presented with dyspnea x2 days: admitted with exacerbation of pulmonary fibrosis due to covid 19 infection & Covid PNA; dx with covid 2 days PTA; tx with maxipime, remdesivir, Vit C, zithromax, rocephin, Vit D, steroids, zinc. patient's family declined to go to rehab, patient family is arranging for him to Rehab from home, ordered recommended home such as bedside commode, wheelchair and son will hire additional help at home to get around with a disability. Leukocytosis secondary to steroids with underlying history of lymphoma.
High fever reaching up to 103.2°F; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 9 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "High fever reaching up to 103.2°F". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever, between 99.7 and 101.0 for 48 hours.   Treatment:  Tylenol